#United States #New York #PR Newswire #Medical Innovation #Health Advances

Weekly Health Recap

Every week, PR Newswire shares a plethora of press releases that highlight crucial advancements and updates in the healthcare sector. With such a high volume of information, discerning the most significant reports can be a challenge. This recap focuses on several noteworthy press releases from the past week, ensuring that healthcare journalists and consumers stay well-informed about the latest developments.

1. Google Cloud and Ai2 Join Forces to Enhance Cancer Research

Google Cloud has announced a significant commitment of $20 million towards the AI-Powered Cancer Research initiative. This collaboration with Ai2 (Allen Institute for Artificial Intelligence) aims to utilize advanced AI tools to facilitate research that could reshape cancer treatment. Google will provide state-of-the-art AI infrastructure while Ai2 brings its expertise in training large-scale models. This initiative promises to push the boundaries of what we understand about cancer and how we combat it.

2. Art Garfunkel Addresses Psoriasis with Sun Pharma

In an inspiring moment, music legend Art Garfunkel has shared his personal journey with psoriasis through a partnership with Sun Pharma. The eight-time Grammy Award winner expressed his readiness to speak about his struggles with the skin condition, signifying a breakthrough in advocacy for patients dealing with similar ailments. His openness aims to promote awareness about ILUMYA® (tildrakizumab-asmn), a medication that has greatly assisted him.

3. H.I.G. Capital Acquires GetixHealth

This week marked a milestone in healthcare finance as H.I.G. Capital successfully acquired GetixHealth, known for its essential revenue cycle management solutions. Anthony Chambers, a Managing Director at H.I.G., emphasized the significance of GetixHealth as a crucial partner to major health systems across the nation. This acquisition aims to streamline healthcare finances and enhance service delivery.

4. Leadership Changes at CVS Health

CVS Health announced a significant transition in its executive leadership this week. Brian Newman has been appointed executive vice president and chief financial officer, ready to take on his new role on April 21. Meanwhile, the company has also appointed Dr. Amy Compton-Phillips as the new chief medical officer, effective May 19. These changes signal a strategic enhancement of CVS Health’s leadership as it continues to navigate the evolving landscape of healthcare.

5. Breakthrough Prizes Celebrate Life Sciences

The Breakthrough Prize Foundation revealed its 2025 laureates in life sciences, fundamental physics, and mathematics this week. The awards recognize extraordinary contributions that can revolutionize healthcare, including innovative treatments for major diseases affecting millions. Co-founders Priscilla Chan and Mark Zuckerberg highlighted the transformative impact of curiosity-driven science in their announcement.

6. Proprio’s AI Surgical Guidance Receives FDA Clearance

Proprio's new technology, which boasts the world's first AI surgical guidance platform, received FDA clearance this week. This groundbreaking advancement enables surgeons to visualize anatomy in 3D during procedures, facilitating real-time success measurement—a significant leap forward in surgical precision and patient outcomes.

7. CMI Media Group and Compas Collaborate with Microsoft Advertising

In an exciting development for healthcare marketing, CMI Media Group and Compas have partnered with Microsoft Advertising. This strategic collaboration aims to enhance client engagement through innovative search engine marketing and display solutions. Justin Freid, Chief Media Innovation Officer, highlighted the significant benefits this partnership brings to healthcare brands.

8. LG Partners with NAMI to Support Mental Health in NCAA

LG Electronics is expanding its mental health support initiative in partnership with NAMI (National Alliance on Mental Illness) for NCAA Final Four host schools. This collaboration aims to increase awareness and provide resources surrounding mental health, along with generous donations to support health-related initiatives on campus.

9. #WearSunscreen Campaign Promotes Sun Safety

Health advocates have launched a campaign aimed at ensuring sunscreen use throughout the year. Dr. Jane Yoo, a board-certified dermatologist, emphasized that every individual should consider sunscreen as an integral part of their daily health regimen, akin to habitual tasks such as brushing teeth.

10. MADD Launches Underage Drinking Prevention Campaign

With prom season approaching, MADD (Mothers Against Drunk Driving) has introduced the “Prom Promise” campaign to help families navigate the risks associated with underage drinking. This unique initiative focuses on creating a contract that teens and parents agree to, fostering a mutual understanding of expectations for a safe, substance-free celebration.

11. Nurses Unaware of Health Risks in IV Bags

A recent survey has revealed alarming statistics indicating that nearly 75% of nurses are unaware of the potential health risks associated with common IV bags. With more than 50% of those surveyed not recognizing the carcinogenic potential of certain chemicals in these bags, this information highlights the urgent need for awareness and education in the healthcare community.

12. Quest Diagnostics’ New Alzheimer's Test

Quest Diagnostics has launched AD-Detect™, a new blood test aimed at confirming Alzheimer's disease. This test offers healthcare providers personalized options along with advanced diagnostic capabilities—an exciting development in the pursuit of better Alzheimer's management.

13. Groundbreaking Study on Depression’s Biomarkers

A landmark study conducted by Amen Clinics reveals that functional brain changes, particularly decreased blood flow, might be more reliable indicators of depression than previously accepted structural brain changes. This research could potentially pave the way for new diagnostic approaches in understanding mental health.

14. AbbVie’s RINVOQ® Approved in Europe

AbbVie has received approval from the European Commission for RINVOQ® (upadacitinib) as a treatment for adults suffering from giant cell arteritis. This approval was based on data showcasing the medication's benefits in managing the condition and improving patient outcomes.

15. Biohaven Presents Innovative Neuroscience Research

At the 2025 American Academy of Neurology (AAN) Annual Meeting, Biohaven showcased data across its neuroscience portfolio. Their innovative approaches could provide new insights into the treatment of various neurological disorders.

These highlights represent just a fraction of the critical information accessible through platforms like PR Newswire. For those in the healthcare field or consumers seeking the latest updates, staying connected and informed is vital for making better health-related decisions.

For more news updates, follow PR Newswire’s ongoing coverage in healthcare.